BACKGROUND: In cancer, tumor escape from the host immune system includes apoptosis of circulating CD3(+)CD8(+) effector T lymphocytes. Here, we compare sensitivity to apoptosis of virus- with tumor-specific circulating CD8(+) T cells in patients with head and neck cancer. METHODS: Wild-type p53 peptide-specific (p53(264-272) and p53(149-157)) and viral peptide-specific (EBV BMLF(259-267) and CMVpp65(495-503)) tetramers were used to measure the frequency of reactive T cells by flow cytometry. Annexin V (ANX) binding to circulating 7-amino-actinomycin D-negative but tetramer(+)CD8(+) T cells in PBMC obtained from 21 patients with head and neck cancer and 11 normal controls (NC) was evaluated. RESULTS: In patients with head and neck cancer, a higher percentage of tetramer(+)CD8(+) than tetramer(-)CD8(+) T cells bound ANX (p < .023-.005). Although most tumor-epitope(+)CD8(+) T cells bound ANX, lower percentages of virus-specific CD8(+) T cells were ANX(+) in the same patients. CONCLUSIONS: Preferential demise of circulating tumor-specific CD8(+) T cells and their paucity in head and neck cancer contribute to tumor escape. (c) 2009 Wiley Periodicals, Inc.
BACKGROUND: In cancer, tumor escape from the host immune system includes apoptosis of circulating CD3(+)CD8(+) effector T lymphocytes. Here, we compare sensitivity to apoptosis of virus- with tumor-specific circulating CD8(+) T cells in patients with head and neck cancer. METHODS: Wild-type p53 peptide-specific (p53(264-272) and p53(149-157)) and viral peptide-specific (EBV BMLF(259-267) and CMVpp65(495-503)) tetramers were used to measure the frequency of reactive T cells by flow cytometry. Annexin V (ANX) binding to circulating 7-amino-actinomycin D-negative but tetramer(+)CD8(+) T cells in PBMC obtained from 21 patients with head and neck cancer and 11 normal controls (NC) was evaluated. RESULTS: In patients with head and neck cancer, a higher percentage of tetramer(+)CD8(+) than tetramer(-)CD8(+) T cells bound ANX (p < .023-.005). Although most tumor-epitope(+)CD8(+) T cells bound ANX, lower percentages of virus-specific CD8(+) T cells were ANX(+) in the same patients. CONCLUSIONS: Preferential demise of circulating tumor-specific CD8(+) T cells and their paucity in head and neck cancer contribute to tumor escape. (c) 2009 Wiley Periodicals, Inc.
Authors: Iris Kuss; Carsten Schaefer; Tony E Godfrey; Robert L Ferris; Jeffrey M Harris; William Gooding; Theresa L Whiteside Journal: Clin Immunol Date: 2005-07 Impact factor: 3.969
Authors: Jeong Whun Kim; Eva Wieckowski; Douglas D Taylor; Torsten E Reichert; Simon Watkins; Theresa L Whiteside Journal: Clin Cancer Res Date: 2005-02-01 Impact factor: 12.531
Authors: Patrick J Schuler; Petra Boeckers; Rainer Engers; Edwin Boelke; Murat Bas; Jens Greve; Claudia A Dumitru; Goetz F Lehnerdt; Robert L Ferris; Pedro A Andrade Filho; Sven Brandau; Stephan Lang; Theresa L Whiteside; Thomas K Hoffmann Journal: J Transl Med Date: 2011-10-04 Impact factor: 5.531
Authors: Andreas E Albers; Xu Qian; Andreas M Kaufmann; Daphne Mytilineos; Robert L Ferris; Thomas K Hoffmann; Albert B DeLeo Journal: Sci Rep Date: 2018-07-16 Impact factor: 4.379